Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.

Authors:
Xin Xin
Xin Xin
Tongji Medical College
China
Na Cui
Na Cui
Peking Union Medical College Hospital
China
Lei Jiang
Lei Jiang
Institute of Chemistry
Ai-min Yang
Ai-min Yang
Lanzhou University
China
Gui-Min Hao
Gui-Min Hao
Hebei Medical University
China

Eur J Obstet Gynecol Reprod Biol 2019 Mar 30;234:207-212. Epub 2019 Jan 30.

Department of Medical Research, Shijiazhuang First Hospital, Hebei Medical University, China.

Objective: To study the effects of long-acting gonadotropin-releasing hormone agonist (GnRH-a) on thyroid function in euthyroid patients of in vitro fertilization (IVF)/ intracytoplasmic sperm injection of embryo transfer (ICSI-ET) and to investigate the timing and alteration of thyroid stimulating hormone (TSH) during controlled ovarian stimulation(COS).

Materials And Methods: Euthyroid patients scheduled for IVF/ICSI were enrolled. Euthyroidism was defined as having no history of hypothyroidism with normal TSH before IVF. Long GnRH-a protocol was chosen as COS protocol. 207 patients were divided into two groups based on basal serum TSH level: group A with 0.35mIU/L<TSH<2.5mIU/L (n = 137) and group B with 2.5mIU/L ≤ TSH<4.5mIU/L (n = 70). Serum TSH was tested on 6 time points: before COS (2-5days in menstrual cycle, before GnRH-a injection), Gn injection day 1, Gn injection day 5, human chorionic gonadotropin (HCG) day, 14 and 28 days after transplantation. The serum TSH, clinical pregnancy and abortion rate were investigated.

Result: The serum TSH value was significantly (P < 0.05) increased after injection of long-acting GnRH-a in all patients. Both groups had significant (P < 0.05) increases in serum TSH level after long-acting GnRH-a injection. The TSH level was increased in 131(63.3%) patients after GnRH-a injection, of which twenty (9.7%) had subclinical hypothyroidism with TSH level over 4.5 mIU/L. The other 76 (36.7%) patients had decreased TSH. In group A, 79 (57.7%) patients showed an increase of TSH, including three patients (2.2%) with simultaneous rise of TPOAb and four (2.9%) diagnosed of subclinical hypothyroidism with TSH level over 4.5 mIU/L, and the rest fifty-eight (42.3%) patients had decreased TSH with one patient with elevated TPOAb who was diagnosed with subclinical hyperthyroidism. In group B, fifty-two (74.3%) patients showed an increase of TSH, including thirteen (18.6%) patients with elevated TPOAb and sixteen (22.9%) patients diagnosed of subclinical hypothyroidism with TSH level over 4.5 mIU/L, and the rest eighteen (25.7%) patients had decreased TSH with one patient diagnosed with subclinical hyperthyroidism. Group B had a significant higher proportion of patients with elevated serum TSH than group A (P < 0.05). Compared to the baseline level, serum TSH ascended distinctly and reached peak level on HCG day in all patients. Group A and B had similar trends of alteration. Patients in group A had significantly (P<0.05) higher clinical pregnancy rate than in group B. No significant (P>0.05) difference in abortion rate were observed between the two groups.

Conclusion: GnRH-a can significantly increase serum TSH levels with possible development of subclinical thyroid dysfunction. Infertile patients with serum TSH > 2.5 mIU/L are more susceptible to GnRH-a while patients with basal TSH less than 2.5 mIU/L may get a higher clinical pregnancy rate when receiving IVF/ICSI.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2019.01.025DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
March 2019
9 Reads
1.627 Impact Factor

Publication Analysis

Top Keywords

serum tsh
16
injection day
8
euthyroid patients
8
stimulating hormone
8
thyroid stimulating
8
controlled ovarian
8
tsh
6
protocol 207
4
207 patients
4
group 035miu/l<tsh<25miu/l
4
cos protocol
4
chosen cos
4
patients divided
4
groups based
4
serum
4
basal serum
4
based basal
4
level group
4
tsh level
4
divided groups
4

Similar Publications